What are the mitotic counts per ten high-power fields for benign, borderline, and malignant phyllodes tumors?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mitotic Counts in Phyllodes Tumors

The mitotic count thresholds for classifying phyllodes tumors are: benign tumors typically show ≤3 mitoses per 10 high-power fields (HPF), borderline tumors show intermediate counts, and malignant tumors demonstrate ≥10 mitoses per 10 HPF, though counts as low as 2-5 mitoses/10 HPF can occur in malignant variants.

Evidence-Based Mitotic Count Ranges

The available research provides specific mitotic count data across phyllodes tumor subtypes:

Benign Phyllodes Tumors

  • ≤3 mitoses/10 HPF is the typical threshold 1
  • Mean mitotic rate of 1.3 mitoses/10 HPF (range 0-6) in usual fibroadenomas 2
  • Mean of 3.1 mitoses/10 HPF in benign phyllodes tumors 2
  • 1 mitosis/10 HPF reported in a case study of benign phyllodes 3

Borderline Phyllodes Tumors

  • ≤3 mitoses/10 HPF in most cases 1
  • 10 mitoses/10 HPF reported in one borderline case 2
  • Borderline tumors occupy an intermediate zone with variable mitotic activity

Malignant Phyllodes Tumors

  • ≥10 mitoses/10 HPF correlates well with histopathologic malignancy 1
  • Range of 2-36 mitoses/10 HPF documented 1
  • Mean of 17 mitoses/10 HPF in malignant cases 2
  • >50% of malignant phyllodes have >5 mitoses/10 HPF 4
  • 4 mitoses/10 HPF reported in one malignant case 3

Critical Clinical Caveats

Mitotic count alone should not determine tumor classification. The NCCN guidelines explicitly state that "no uniform agreement exists on the criteria for assigning subtype" 5. The consensus approach requires integrating multiple histologic features:

  • Stromal cellularity
  • Cellular atypia and nuclear pleomorphism
  • Tumor border characteristics (infiltrative vs. pushing)
  • Stromal overgrowth
  • Presence of necrosis

Important pitfall: Adolescent patients can show substantial mitotic activity even in benign fibroepithelial lesions (up to 6 mitoses/10 HPF in usual fibroadenomas), which should be interpreted cautiously to avoid overdiagnosis 2. The pubertal hormonal surge impacts both growth and microscopic appearance.

Prognostic Significance

Only high mitotic rates (≥10/10 HPF) correlate reliably with malignancy 1. Lower counts require careful integration with other histologic parameters. Notably, stromal overgrowth correlates strongly with mitotic activity, tumor size >10 cm, rapid growth, and local recurrence risk 6.

Margin status supersedes histologic grade in predicting recurrence risk 5. The NCCN guidelines emphasize that tumor-free margins of ≥1 cm are more important than subtype classification for preventing local recurrence.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.